FeesSafety
Pluang+

Immunic appoints Jaa Roberson as Chief People Officer to strengthen leadership ahead of Phase 3 MS trial data.

Market News
19 Oct 2026, 13:30 WIB
PRNewsWire
View Source
Bullish
Immunic appoints Jaa Roberson as Chief People Officer to strengthen leadership ahead of Phase 3 MS trial data.

Immunic, a late-stage biotech company focused on neurologic diseases, has appointed Jaa Roberson as Chief People Officer to lead global talent and organizational strategy. This move supports Immunic's goal to build a strong multiple sclerosis (MS) organization ahead of pivotal Phase 3 trial results expected by the end of 2026 and potential commercialization of its drug vidofludimus calcium. Roberson brings over 20 years of HR experience in biopharma and will help scale the company from research to a fully integrated commercial entity. The appointment aligns with Immunic's preparation for regulatory filings and expanding its MS-focused team.

Immunic's leadership change is noted here with Pluang's Health sector data for context. As of Oct 19, 2026 17:11 WIB, 69 of 150 Health-sector US stocks on Pluang rose, 45 fell. Notable movers include AMRX at USD 19.55 (+1.93%), RLAY at USD 16.59 (+1.90%), and ERAS at USD 13.63 (+1.79%).

More News

SI-BONE Q3 revenue rises 15% to $55.7M; new Onyx device expands market to $5B

SI-BONE Q3 revenue rises 15% to $55.7M; new Onyx device expands market to $5B

SI-BONE reported a 15% increase in third-quarter 2026 revenue to $55.7 million, driven by growing adoption of its surgical implants. The launch of the iFuse Granite Onyx device, approved by the FDA, expands the company's addressable market to $5 bill...

Company Fundamentals
Bullish
8 minutes ago
Nvidia, Coherent, and Dell report strong AI-driven growth despite recent stock drops.

Nvidia, Coherent, and Dell report strong AI-driven growth despite recent stock drops.

Nvidia, Coherent, and Dell Technologies all supply key components for AI infrastructure and have reported strong revenue growth despite significant stock price declines. Nvidia's data center revenue rose 21% sequentially, with a fiscal Q4 revenue for...

Bullish
22 minutes ago
BridgeBio's Attruby revenue soars 134% YoY; FDA decision for BBP-418 due Nov 27

BridgeBio's Attruby revenue soars 134% YoY; FDA decision for BBP-418 due Nov 27

BridgeBio reported a 134% year-over-year increase in net product revenue for Attruby, reaching $253.2 million in Q3 2026, driven by new patients starting treatment for transthyretin amyloid cardiomyopathy. The company anticipates an FDA decision on N...

Company Fundamentals
Bullish
50 minutes ago
Altria raises dividends for 57 years but faces declining cigarette sales and high payout risks.

Altria raises dividends for 57 years but faces declining cigarette sales and high payout risks.

Altria Group has increased its dividends for 57 consecutive years, maintaining a strong yield of 5.9%, well above the S&P 500 average. However, the company's cigarette sales volumes continue to decline, with a 2.8% drop in cigarette volume this year ...

Company Fundamentals
Neutral
51 minutes ago
Everforth's Q3 revenue tops $1B; cybersecurity bookings surge 40% amid rising AI adoption.

Everforth's Q3 revenue tops $1B; cybersecurity bookings surge 40% amid rising AI adoption.

Everforth reported $1.03 billion in revenue for Q3 2026, surpassing company guidance. The firm sees enterprise software as the key channel for AI deployment, with strong growth in cybersecurity and risk bookings, up over 40% year-to-date due to incre...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App